ANURAS.NS
ANURAS.NS
INE930P01018
ANUPAM RASAYAN INDIA LTD
Loading chart...

Company Profile

Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments, Life Science related Specialty Chemicals and Performance Material. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients. It provides specialty monomers, ionomers, and oligomers for defence, aerospace, and semiconductors applications; niche molecules for the electronic ecosystem; and materials for backend and frontend semiconductor processes, including battery chemicals. The company was incorporated in 1984 and is headquartered in Surat, India.

Related stocks

PRIVISCL.BO
PRIVISCL.BO • India
PRIVI SPECIALITY CHEMICALS LIM
3,426.25 INR
1.38B USD 1Y +38.1%
JSWDULUX.NS
JSWDULUX.NS • India
JSW DULUX LIMITED
3,005.1 INR
1.41B USD 1Y -10.7%
VINATIORGA.BO
VINATIORGA.BO • India
VINATI ORGANICS LTD.
1,123.85 INR
1.2B USD 1Y -33.8%
SHAILY.BO
SHAILY.BO • India
SHAILY ENGINEERING PLASTICS LT
3,063.5 INR
1.46B USD 1Y +29.6%
ATUL.NS
ATUL.NS • India
ATUL LTD
5,882.5 INR
1.79B USD 1Y -1.5%
SPLPETRO.BO
SPLPETRO.BO • India
SUPREME PETROCHEM LTD.
789.15 INR
1.53B USD 1Y -1.8%
FINEORG.NS
FINEORG.NS • India
FINE ORGANIC IND. LTD.
5,410.5 INR
1.71B USD 1Y +17%
BASF.NS
BASF.NS • India
BASF INDIA LTD
3,347.4 INR
1.5B USD 1Y -28.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
29.8% p.a.
Max Drawdown (5Y)
-48.5%
Sharpe Ratio (5Y)
0.17
Beta Factor
0.13
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 73.6 (Elevated multiple compression risk)
Strong cyclicality: The business model is sensitive to economic downturns.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (29.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -48.5% in the extended horizon.
ende